creatine and dextrose for long covid

The short version: the evidence for creatine plus dextrose in long COVID is thin, but a small 2025 trial of creatine alone shows real promise for fatigue and muscle symptoms.

The best evidence you have is a single randomized, double-blind, placebo-controlled trial of 12 adults with post-viral fatigue syndrome after COVID-19. They took 4 grams of creatine monohydrate per day for 6 months. The study found improvements in general fatigue, exercise tolerance, and specific symptoms like ageusia, body aches, and headache by the 6-month mark [16]. The same review also reported a separate observational finding: 19 long COVID patients had markedly reduced creatine levels in muscle and brain tissue, and the lower the muscle creatine, the worse the myalgia [16]. That gives you a plausible mechanism—if the disease depletes creatine, replenishing it might help.

The dextrose part of your question has no direct evidence in long COVID. The rationale comes from older sports nutrition research showing that co-ingesting carbohydrate with creatine increases whole-body creatine retention, likely because insulin stimulates muscle uptake [2]. That is a well-established finding in healthy athletes, but it has never been tested in long COVID patients. Whether the small extra uptake matters for someone who is not doing high-intensity exercise is unknown.

The evidence base is very small. One trial of 12 people, one observational finding of 19 people. No manufacturer funded this—the review was published in a mainstream journal without obvious industry ties [16]. The safety record for creatine in the short term is clean: no liver or kidney function changes in healthy adults taking 20 grams per day for 5 days [2]. Long-term safety data is absent, but 4 grams per day for 6 months produced only mild transient nausea in one participant [16].

My call: creatine alone at 4 g/day is a low-risk, plausibly helpful intervention for long COVID fatigue and muscle symptoms, supported by one small but direct trial. Adding dextrose has no evidence in this population but is unlikely to cause harm. Confidence: low—the trial is tiny and unreplicated, but the mechanism and safety profile are reasonable.